A23V 2250/5112
Cyclodextrin
A23V2250/5112 (Cyclodextrin) appears on 4 US grants and 7 published applications in this corpus.
Search patents in A23V- Granted patents
- 4
- Published applications
- 7
- Assignees
- 7
- Inventors
- 17
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 2 |
| 2019 | 0 | 3 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 2 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Shelf-stable nitrogenous organic acid compositions10 Mar 2026US 12,568,993 B2Glanbia Dairy Nutrition Limited
- Cannabinoid-containing composition30 May 2023US 11,660,283 B2Joyn Botanicals Ltd.
- Base emulsion for the preparation of icings, fillings and toppings5 Apr 2022US 11,291,216 B2Brill, Inc.
- Dietary supplement compositions including cannabidiol formulations having enhanced bioavailability with sustained time release and enhanced organoleptics, and methods of making same22 Feb 2022US 11,252,985 B1Cannasphere Biotech, LLC.
- Cannabinoid-Containing Composition7 Oct 2021US 2021/0308095 A1Joyn Botanicals Ltd.
- Cannabinoid-Containing Composition25 Jun 2020US 2020/0197353 A1Joyn Botanicals Ltd.
- Shelf-Stable Nitrogenous Organic Acid Compositions1 Aug 2019US 2019/0230960 A1Glanbia Nutritionals (Ireland) Ltd.
- Base emulsion for the preparation of icings, fillings and toppings4 Jul 2019US 2019/0200634 A1CSM Bakery Solutions Europe Holding B.V.
- Devices and methods for preparing and administering a nutritional formula14 Mar 2019US 2019/0075835 A1Alcresta Therapeutics, Inc.
Most cited
By later US patents